Hysteroscopic management of cesarean scar pregnancy after unsuccessful methotrexate treatment.
Current management of cesarean scar pregnancy is conservative and consists of medical treatment with methotrexate (MTX). We present a report on a woman with this type of pregnancy who had continuous vaginal bleeding and persistent serum levels of beta human chorionic gonadotropin after undergoing curettage and MTX. Eventually, the remaining ectopic gestational tissue was removed by operative hysteroscopy.
Chao
Angel
A
Department of Obstetrics and Gynecology, Chang Gung University, Tao-Yuan, Taiwan. angel945@adm.cgmh.org.tw
Wang
Tzu-Hao
TH
Wang
Chin-Jung
CJ
Lee
Chyi-Long
CL
Chao
An-Shine
AS
D000020:Abortifacient Agents, Nonsteroidal / Q000627:therapeutic use*; D000328:Adult; D002585:Cesarean Section; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D002921:Cicatrix / Q000150:complications*; D005260:Female; D006801:Humans; D015907:Hysteroscopy; D008727:Methotrexate / Q000627:therapeutic use*; D011247:Pregnancy; D011271:Pregnancy, Ectopic / Q000097:blood / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000601:surgery*; D017211:Treatment Failure; D016216:Ultrasonography, Prenatal
D000020:Abortifacient Agents, Nonsteroidal; D018997:Chorionic Gonadotropin, beta Subunit, Human; D008727:Methotrexate